AS Latvijas Juras medicinas centrs (UOM.MU)
EUR 6.0
(0.0%)
EUR 6.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 376.09 Thousand EUR | -51.46% |
| 2022 | 774.74 Thousand EUR | -36.35% |
| 2021 | 1.21 Million EUR | 105.29% |
| 2020 | 592.89 Thousand EUR | 30.29% |
| 2019 | 455.05 Thousand EUR | 39.42% |
| 2018 | 326.38 Thousand EUR | -36.47% |
| 2017 | 513.76 Thousand EUR | 42.75% |
| 2016 | 359.89 Thousand EUR | 60.09% |
| 2015 | 224.81 Thousand EUR | -46.79% |
| 2014 | 422.52 Thousand EUR | 4318.49% |
| 2013 | -10.01 Thousand EUR | -103.9% |
| 2012 | 257.14 Thousand EUR | 49.97% |
| 2011 | 171.46 Thousand EUR | 119.0% |
| 2010 | 78.29 Thousand EUR | -78.76% |
| 2009 | 368.59 Thousand EUR | -40.12% |
| 2008 | 615.54 Thousand EUR | -26.45% |
| 2007 | 836.93 Thousand EUR | 48.08% |
| 2006 | 565.19 Thousand EUR | -2.29% |
| 2005 | 578.43 Thousand EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 197.62 Thousand EUR | 4686.4% |
| 2024 Q2 | -20.82 Thousand EUR | -110.54% |
| 2023 Q4 | -4309.00 EUR | -101.41% |
| 2023 Q1 | -20.73 Thousand EUR | -123.69% |
| 2023 FY | 376.09 Thousand EUR | -51.46% |
| 2023 Q3 | 306.6 Thousand EUR | 1628.62% |
| 2023 Q2 | 17.73 Thousand EUR | 185.55% |
| 2022 Q1 | 485.88 Thousand EUR | 38.54% |
| 2022 Q3 | 142.29 Thousand EUR | 141.04% |
| 2022 Q2 | 59.03 Thousand EUR | -87.85% |
| 2022 Q4 | 87.52 Thousand EUR | -38.49% |
| 2022 FY | 774.74 Thousand EUR | -36.35% |
| 2021 Q3 | 342.61 Thousand EUR | 45.97% |
| 2021 Q2 | 234.72 Thousand EUR | -18.81% |
| 2021 Q4 | 350.71 Thousand EUR | 2.36% |
| 2021 FY | 1.21 Million EUR | 105.29% |
| 2021 Q1 | 289.11 Thousand EUR | 1834.74% |
| 2020 FY | 592.89 Thousand EUR | 30.29% |
| 2020 Q1 | 150.32 Thousand EUR | -16.66% |
| 2020 Q2 | 164.25 Thousand EUR | 9.27% |
| 2020 Q3 | 294.97 Thousand EUR | 79.58% |
| 2020 Q4 | -16.66 Thousand EUR | -105.65% |
| 2019 Q4 | 180.36 Thousand EUR | -34.95% |
| 2019 Q1 | 71.07 Thousand EUR | -48.07% |
| 2019 Q3 | 277.26 Thousand EUR | 476.42% |
| 2019 FY | 455.05 Thousand EUR | 39.42% |
| 2019 Q2 | -73.65 Thousand EUR | -203.63% |
| 2018 Q1 | 133.12 Thousand EUR | -41.26% |
| 2018 FY | 326.38 Thousand EUR | -36.47% |
| 2018 Q4 | 136.87 Thousand EUR | 12.59% |
| 2018 Q3 | 121.56 Thousand EUR | 286.51% |
| 2018 Q2 | -65.17 Thousand EUR | -148.96% |
| 2017 Q2 | -124.81 Thousand EUR | -178.57% |
| 2017 Q1 | 158.85 Thousand EUR | 11.84% |
| 2017 FY | 513.76 Thousand EUR | 42.75% |
| 2017 Q3 | 253.1 Thousand EUR | 302.79% |
| 2017 Q4 | 226.61 Thousand EUR | -10.46% |
| 2016 Q1 | 98.22 Thousand EUR | -27.84% |
| 2016 Q4 | 142.04 Thousand EUR | -8.52% |
| 2016 FY | 359.89 Thousand EUR | 60.09% |
| 2016 Q3 | 155.26 Thousand EUR | 535.79% |
| 2016 Q2 | -35.62 Thousand EUR | -136.27% |
| 2015 Q4 | 136.11 Thousand EUR | 32.04% |
| 2015 Q3 | 103.08 Thousand EUR | 618.9% |
| 2015 Q1 | -28.72 Thousand EUR | -181.69% |
| 2015 Q2 | 14.33 Thousand EUR | 149.92% |
| 2015 FY | 224.81 Thousand EUR | -46.79% |
| 2014 Q4 | 35.15 Thousand EUR | -84.39% |
| 2014 Q1 | 150.61 Thousand EUR | -16.47% |
| 2014 Q3 | 225.21 Thousand EUR | 1851.25% |
| 2014 FY | 422.52 Thousand EUR | 4318.49% |
| 2014 Q2 | 11.54 Thousand EUR | -92.34% |
| 2013 Q4 | 180.3 Thousand EUR | 97.55% |
| 2013 FY | -10.01 Thousand EUR | -103.9% |
| 2013 Q3 | 91.27 Thousand EUR | 157.13% |
| 2013 Q1 | -121.83 Thousand EUR | -135.13% |
| 2013 Q2 | -159.76 Thousand EUR | -31.13% |
| 2012 Q4 | 346.79 Thousand EUR | 661.87% |
| 2012 FY | 257.14 Thousand EUR | 49.97% |
| 2012 Q1 | 50.09 Thousand EUR | -68.51% |
| 2012 Q2 | -78.02 Thousand EUR | -255.75% |
| 2012 Q3 | -61.72 Thousand EUR | 20.9% |
| 2011 Q2 | -97.72 Thousand EUR | -211.89% |
| 2011 FY | 171.46 Thousand EUR | 119.0% |
| 2011 Q1 | 87.33 Thousand EUR | 933.84% |
| 2011 Q4 | 159.1 Thousand EUR | 599.57% |
| 2011 Q3 | 22.74 Thousand EUR | 123.27% |
| 2010 Q4 | 8448.00 EUR | -97.52% |
| 2010 Q1 | -61.96 Thousand EUR | -344.19% |
| 2010 FY | 78.29 Thousand EUR | -78.76% |
| 2010 Q2 | -208.35 Thousand EUR | -236.27% |
| 2010 Q3 | 340.15 Thousand EUR | 263.26% |
| 2009 Q2 | 147.97 Thousand EUR | 4.62% |
| 2009 Q3 | 53.8 Thousand EUR | -63.64% |
| 2009 FY | 368.59 Thousand EUR | -40.12% |
| 2009 Q4 | 25.37 Thousand EUR | -52.84% |
| 2009 Q1 | 141.44 Thousand EUR | 0.0% |
| 2008 FY | 615.54 Thousand EUR | -26.45% |
| 2007 FY | 836.93 Thousand EUR | 48.08% |
| 2006 FY | 565.19 Thousand EUR | -2.29% |
| 2005 FY | 578.43 Thousand EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|